Cyanidin-3-O-Glucoside improves the viability of human islet cells treated with amylin or Aβ(1-42) in vitro

Islet transplantation is being considered as an alternative treatment for type 1 diabetes. Despite recent progress, transplant recipients continue to experience progressive loss of insulin independence. Cyanidin-3-O-Glucoside (C3G) has shown to be protective against damage that may lead to post-tran...

Descripción completa

Detalles Bibliográficos
Autores principales: Croden, Jennifer, Silva, Josue Rodrigues, Huang, Wenlong, Gupta, Nancy, Fu, Wen, Matovinovic, Kaja, Black, Mazzen, Li, Xian, Chen, Kunsong, Wu, Yulian, Jhamandas, Jack, Rayat, Gina R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494376/
https://www.ncbi.nlm.nih.gov/pubmed/34614009
http://dx.doi.org/10.1371/journal.pone.0258208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494376/
https://www.ncbi.nlm.nih.gov/pubmed/34614009
http://dx.doi.org/10.1371/journal.pone.0258208

Ejemplares similares